IRCM, Univ. Montpellier, ICM, INSERM, Montpellier, France.
BCM, Univ. Montpellier, CNRS, INSERM, Montpellier, France.
J Immunol Methods. 2024 Sep;532:113730. doi: 10.1016/j.jim.2024.113730. Epub 2024 Jul 25.
Most antibodies used in immunohistochemistry (IHC) have been developed by animal immunization. We wanted to explore naive antibody repertoires displayed on filamentous phages as a source of full-length antibodies for IHC on Formalin-Fixed and Paraffin-Embedded (FFPE) tissues. We used two isogenic mouse fibroblast cell lines that express or not human HER2 to generate positive and negative FFPE pseudo-tissue respectively. Using these pseudo-tissues and previously described approaches based on differential panning, we isolated very efficient antibody clones, but not against HER2. To optimize HER2 targeting and tissue specificity, we first performed 3-4 rounds of in vitro panning using recombinant HER2 extracellular domain (ECD) to enrich the phage library in HER2 binders, followed by one panning round using the two FFPE pseudo-tissues to retain binders for IHC conditions. We then analyzed the bound phages using next-generation sequencing to identify antibody sequences specifically associated with the HER2-positive pseudo-tissue. Using this approach, the top-ranked clone identified by sequencing was specific to the HER2-positive pseudo-tissue and showed a staining pattern similar to that of the antibody used for the clinical diagnosis of HER2-positive breast cancer. However, we could not optimize staining on other tissues, showing that specificity was restricted to the tissue used for selection and screening. Therefore, future optimized protocols must consider tissue diversity early during the selection by panning using a wide collection of tissue types.
大多数用于免疫组织化学(IHC)的抗体都是通过动物免疫产生的。我们希望探索丝状噬菌体上展示的天然抗体库,作为用于福尔马林固定和石蜡包埋(FFPE)组织的 IHC 的全长抗体的来源。我们使用了两个表达或不表达人 HER2 的同基因小鼠成纤维细胞系,分别生成阳性和阴性 FFPE 假组织。使用这些假组织和之前基于差异淘选描述的方法,我们分离出了非常有效的抗体克隆,但不是针对 HER2 的。为了优化 HER2 靶向和组织特异性,我们首先使用重组 HER2 细胞外结构域(ECD)进行了 3-4 轮体外淘选,以富集针对 HER2 的结合物的噬菌体文库,然后使用两种 FFPE 假组织进行一轮淘选,以保留适用于 IHC 条件的结合物。然后,我们使用下一代测序分析结合的噬菌体,以鉴定与 HER2 阳性假组织特异性相关的抗体序列。使用这种方法,通过测序确定的排名最高的克隆特异性针对 HER2 阳性假组织,并显示出与用于 HER2 阳性乳腺癌临床诊断的抗体相似的染色模式。然而,我们无法优化其他组织的染色,表明特异性仅限于用于选择和筛选的组织。因此,未来的优化方案必须在使用广泛的组织类型进行淘选时,在早期选择过程中考虑组织多样性。